收费全文 | 265692篇 |
免费 | 13933篇 |
国内免费 | 874篇 |
耳鼻咽喉 | 3583篇 |
儿科学 | 7253篇 |
妇产科学 | 5422篇 |
基础医学 | 36676篇 |
口腔科学 | 7764篇 |
临床医学 | 19140篇 |
内科学 | 58845篇 |
皮肤病学 | 6305篇 |
神经病学 | 22778篇 |
特种医学 | 8062篇 |
外国民族医学 | 2篇 |
外科学 | 35843篇 |
综合类 | 1623篇 |
一般理论 | 218篇 |
预防医学 | 26911篇 |
眼科学 | 6292篇 |
药学 | 18972篇 |
中国医学 | 840篇 |
肿瘤学 | 13970篇 |
2023年 | 1557篇 |
2022年 | 1924篇 |
2021年 | 5968篇 |
2020年 | 3334篇 |
2019年 | 5865篇 |
2018年 | 8433篇 |
2017年 | 5475篇 |
2016年 | 5623篇 |
2015年 | 6289篇 |
2014年 | 7888篇 |
2013年 | 11074篇 |
2012年 | 17903篇 |
2011年 | 18589篇 |
2010年 | 9765篇 |
2009年 | 7754篇 |
2008年 | 15281篇 |
2007年 | 15749篇 |
2006年 | 15231篇 |
2005年 | 14739篇 |
2004年 | 13484篇 |
2003年 | 12532篇 |
2002年 | 11733篇 |
2001年 | 5804篇 |
2000年 | 6293篇 |
1999年 | 5090篇 |
1998年 | 1691篇 |
1997年 | 1243篇 |
1996年 | 1066篇 |
1995年 | 1023篇 |
1992年 | 2678篇 |
1991年 | 2397篇 |
1990年 | 2353篇 |
1989年 | 2025篇 |
1988年 | 1955篇 |
1987年 | 1816篇 |
1986年 | 1889篇 |
1985年 | 1795篇 |
1984年 | 1433篇 |
1983年 | 1233篇 |
1979年 | 1373篇 |
1978年 | 1009篇 |
1975年 | 1027篇 |
1974年 | 1282篇 |
1973年 | 1301篇 |
1972年 | 1238篇 |
1971年 | 1197篇 |
1970年 | 1099篇 |
1969年 | 1168篇 |
1968年 | 1171篇 |
1967年 | 1021篇 |
Purpose
A hydrogel rectal spacer (HRS) is a medical device that is approved by the U.S. Food and Drug Administration to increase the separation between the prostate and rectum. We conducted a cost-effectiveness analysis of HRS use for reduction in radiation therapy (RT) toxicities in patients with prostate cancer (PC) undergoing external beam RT (EBRT).Methods and Materials
A multistate Markov model was constructed from the U.S. payer perspective to examine the cost-effectiveness of HRS in men with localized PC receiving EBRT (EBRT alone vs EBRT + HRS). The subgroups analyzed included site of HRS placement (hospital outpatient, physician office, ambulatory surgery center) and proportion of patients with good baseline erectile function (EF). Data on EF, gastrointestinal and genitourinary toxicities incidence, and potential risks associated with HRS implantation were obtained from a recently published randomized clinical trial. Health utilities and costs were derived from the literature and the 2018 Physician Fee Schedule and were discounted 3% annually. Quality-adjusted life years (QALYs) and costs were modeled for a 5-year period from receipt of RT. Probabilistic sensitivity analysis and value-based threshold analyses were conducted.Results
The per-patient 5-year incremental cost for spacers administered in a hospital outpatient setting was $3578, and the incremental effectiveness was 0.0371 QALYs. The incremental cost-effectiveness ratio was $96,440/QALY for patients with PC undergoing HRS insertion in a hospital and $39,286/QALY for patients undergoing HRS insertion in an ambulatory facility. For men with good baseline EF, the incremental cost-effectiveness ratio was $35,548/QALY and $9627/QALY in hospital outpatient and ambulatory facility settings, respectively.Conclusions
Based on the current Medicare Physician Fee Schedule, HRS is cost-effective at a willingness to pay threshold of $100,000. These results contain substantial uncertainty, suggesting more evidence is needed to refine future decision-making. 相似文献Methods: The purpose of this study was to examine the degree to which several personal factors and school characteristics affect and explain students’ self-determination. A total of 232 students with intellectual disability from Spain participated. Their self-determination level was assessed by the ARC-INICO Scale.
Results: Students with moderate levels of intellectual disability obtained significantly lower scores on self-determination than their peers with mild intellectual disability. There were significant differences in relation to the level of support needs and their experience with transition programs. The level of support needs was a significant predictor.
Conclusion: These findings contribute to current research in this field and practical implications were discussed. 相似文献